LCM
PFE icon

Lewis Capital Management’s Pfizer PFE Stock Holding History

Lewis Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$880K Buy
26,522
+1,734
+7% +$61.3K 1.37% 19
2023
Q2 		$909K Hold
24,788
– – 1.3% 22
2023
Q1 		$1.01M Sell
24,788
-1,102
-4% -$47.6K 1.52% 17
2022
Q4 		$1.33M Hold
25,890
– – 2.03% 12
2022
Q3 		$1.13M Sell
25,890
-458
-2% -$22.3K 1.74% 14
2022
Q2 		$1.38M Buy
26,348
+3
+0% +$153 1.97% 13
2022
Q1 		$1.36M Sell
26,345
-370
-1% -$19.2K 1.55% 17
2021
Q4 		$1.58M Buy
+26,715
New +$1.32M 1.65% 15

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lewis Capital Management's PFE Position: Q3 2023 in Review

Lewis Capital Management increased its Pfizer (PFE) stake by 7% in Q3 2023, buying an estimated $61.3K and bringing the position to 26,522 shares worth $880K. The position accounts for 1.37% of the portfolio, ranked #19.

Lewis Capital Management first reported a position in PFE in Q4 2021 and has held it in 8 quarters since. The position peaked at $1.58M in Q4 2021. 2,926 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

  • Lewis Capital Management held 26,522 shares of Pfizer worth $880K as of Q3 2023.
  • Lewis Capital Management bought 1,734 Pfizer shares in Q3 2023, an estimated $61.3K.
  • Pfizer made up 1.37% of Lewis Capital Management's portfolio in Q3 2023, its #19 holding.
  • Lewis Capital Management first reported a position in Pfizer in Q4 2021 and has held it in 8 quarters since.
  • Lewis Capital Management's Pfizer position peaked at $1.58M in Q4 2021.
  • 2,926 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Lewis Capital Management's 13F filing for Q3 2023, filed 8 Nov 2023.